The WACC of Evelo Biosciences Inc (EVLO) is 8.6%.
| Range | Selected | |
| Cost of equity | 11,169.90% - 21,779.20% | 16,474.55% |
| Tax rate | 0.30% - 0.40% | 0.35% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 7.4% - 9.7% | 8.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 2427.4 | 3888.27 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 11,169.90% | 21,779.20% |
| Tax rate | 0.30% | 0.40% |
| Debt/Equity ratio | 4593.83 | 4593.83 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 7.4% | 9.7% |
| Selected WACC | 8.6% | |